Pluri

A biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures.

Health Tech & Life Sciences
public
Public Haifa, Israel Founded 2001
Last updated 2026-11-09
Total raised
$219.8M
Last: Undisclosed Round 2026-06
Stage
Public
Founded
2001
Headcount
93
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli biotechnology company engaged in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform. It also offers cell manufacturing services and cell-based coffee, and develops and commercializes cultivated meat products. Pluri operates in the fields of regenerative medicine, food tech, immunotherapy, CDMO, and AgTech, utilizing its unique three-dimensional (3D) technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice (GMP) cell manufacturing facility. [5, 11, 23]

Funding history · 18 rounds · $219.8M total

18 events/rounds · $219.8M Total Funding: $68.5M in Private Equity, $70.1M in Public Equity, $50.0M in Debt
Oct 2026
PIPE $1.0M EDGAR filing SEC-EDGAR 8-K
Aug 2026
Public Offering $3.3M EDGAR filing SEC-EDGAR 424B5
Dec 2025
PIPE $2.5M EDGAR filing SEC-EDGAR 8-K
Feb 2024
Public Offering $10.0M EDGAR filing SEC-EDGAR 424B5
Dec 2022
PIPE Undisclosed EDGAR filing SEC-EDGAR 8-K
Sep 2022
Public Offering $11.8M EDGAR filing SEC-EDGAR 424B5
Feb 2021
Public Offering $30.0M EDGAR filing SEC-EDGAR 8-K
May 2020
Public Offering $15.0M EDGAR filing SEC-EDGAR 8-K
Apr 2020
Debt Financing $50.0M EDGAR filing SEC-EDGAR 8-K
Mar 2019
PIPE $20.0M prior (startupim db)
Dec 2016
PIPE $15.0M prior (startupim db)
Sep 2016
PIPE $30.0M prior (startupim db)
May 2015
Public Offering Undisclosed prior (startupim db)
May 2015
Grant $2.9M prior (startupim db)
Nov 2010
Public Offering Undisclosed prior (startupim db)
Mar 2003
Public Offering Undisclosed prior (startupim db)

Acquisitions · 1

Apr 2025
Kokomodo Ltd. Undisclosed

Offices

Haifa, Israel · HQ / main office

Q&A

What is Pluri's primary business?
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli biotechnology company focused on the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries, including regenerative medicine, food tech, immunotherapy, CDMO, and AgTech.
When was Pluri founded and where is its headquarters located?
Pluri was founded in May 2001 and is headquartered in Haifa, Israel.
What was Pluri's most recent public offering?
Pluri completed a public offering in February 2024, raising $10,000,000.
What was the amount of Pluri's debt financing round in April 2020?
In April 2020, Pluri secured $50,000,000 in debt financing.
Which organizations provided grants to Pluri in May 2016?
In May 2016, Pluri received a $3,300,000 grant from the Israel Innovation Authority and the European Union's Horizon 2020 program.
What is Pluri's total funding raised to date?
Pluri has raised a total of $219,843,400 to date.
Has Pluri made any acquisitions?
Yes, Pluri acquired Kokomodo Ltd. in April 2025.

Team · 14

Shai Meretzki
Founder · founders
Zami Aberman
Founder · founders
Dr. Yael Porat
Founder · founders
Doron Shorrer
Founder · Director
Yaky Yanay
CEO & President
Liat Zalts
CFO & Treasurer
Ori Shalem
Vice President of Operations & Manufacturing
Efrat Kaduri
Chief Business Development Officer – Pharma
Nofar Glaich-Dabach
VP Human Resources
Nimrod Bar Zvi
Chief Commercial Officer
Lior Raviv
Chief Technology Officer
Alejandro Weinstein
Chairman of the Board
Maital Shemesh-Rasmussen
Independent Director
Rami Levi
Independent Director

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B

Highlights

Climate TechPatents

Tags

orthopedicsinflammatory-diseasespulmonarybiological-therapyregenerative-medicinestem-cellscell-therapybioprocesscardiovascularpharmaceuticals3d-technologyspace-techpharma-companiespatientsfood-techagtechimmunotherapycdmocellular-agriculture
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepluri-biotech.com/
LinkedInlinkedin.com/company/pluri-biotech
X / Twittertwitter.com/Pluribiotech

Identifiers & details

Legal namePluri Inc.
Founded2001-5
Employees (exact)93

Acquisitions & public offerings

AcquiredDateAmount
Kokomodo Ltd.2025-04

Radar intelligence

Patents

EPO20

Publications (Crossref)

Works10

Web history (Wayback)

Domainpluri-biotech.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)513371666
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2003-01-22
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events7 — people (4), other (1), charge (2)
Registered addressמרכז תעשיות מדע ,דואר מת~מ 20 חיפה

Recent registry events

DateEvent
2026-06-24עדכון דירקטורים-הוספת דירקטור
2026-01-22עדכון דירקטורים-עדכון מנהלים
2025-11-17עדכון כתובת ו/או מען דיגיטלי
2025-11-16סילוק שעבוד
2026-06-16עדכון דירקטורים-הסרת דירקטור
2026-06-16עדכון בעלי תפקידים
2026-05-13סילוק שעבוד